Introduction. The multi-puncture BCG vaccine was withdrawn from the market in 2006, and the mandatory vaccination requirement was replaced in 2007 by a strong recommendation for...

Resistance to antituberculosis drugs emerged as soon as they were first used. Currently, in France, the main risk factor for resistance remains having previously received...

Pediatric tuberculosis, a disease that still affects children in Europe today, deserves special attention. In 2010, 3,035 cases of pediatric tuberculosis (ages 0–14) were reported, with...

Among patients with tuberculosis who were born abroad, the average time from their most recent stay abroad to the onset of tuberculosis is less than 4 years, whereas the time from their...

Introduction. Tetanus, a severe acute toxic infection that is often fatal, can be prevented through vaccination. This report presents cases reported in France between 2008 and 2011....

Introduction. This article describes the general public’s knowledge, perceptions, and practices regarding screening and vaccination for hepatitis B virus (HBV), in comparison to those...

Introduction. In France, hepatitis B vaccination coverage among the populations targeted by vaccination guidelines (high-risk individuals, infants, children, and adolescents) remains...

Introduction. In France, more than 220,000 people are living with chronic hepatitis C. Nevertheless, the general public remains largely unaware of the disease. Little data is available,...

Introduction. Treatment failures with INF-PEGa2a/b and ribavirin in chronic hepatitis C are primarily due to poor adherence and side effects. No prospective study had yet validated the...